Private Label Tranexamic & Kojic Acid Eye Serum Low MOQ

The minimum order quantity for a private label tranexamic acid and kojic acid eye serum depends primarily on whether you choose a stock base formula, a semi-custom modification, or a fully original formula developed from scratch. For stock base formulas — where the cosmetic contract manufacturer already has a validated brightening eye serum base they adapt with your label and potentially minor fragrance or preservative tweaks — MOQs can be as low as 100 to 300 units. These are the lowest-barrier entry points for indie founders testing market demand before committing to a larger run. Semi-custom development, where you modify an existing base to adjust active concentrations, pH, texture, or add additional actives like niacinamide or peptides, typically carries MOQs of 300 to 1,000 units. The manufacturer needs to produce enough volume to justify the lab work, raw material minimum purchases, and filling line setup time. Fully custom formulas developed from scratch — your own proprietary cosmetic chemist specification or a brief you bring to a formulation lab — generally require 500 to 2,000 units minimum, with many larger contract manufacturers setting their floor at 1,000 units or higher once packaging customization is included. Several factors can push MOQs up: choosing a premium airless pump or specialty glass packaging (which has its own supplier MOQ), requesting custom color or scent in the formula, targeting a very specific active concentration that requires special raw material sourcing, and working with manufacturers who prioritize larger brands over startups. To find manufacturers that genuinely offer low MOQs in the brightening serum category, the most efficient approach is using a marketplace purpose-built for cosmetics sourcing. AJ Cosmo Labs lets you filter manufacturers by MOQ directly in the iOS app so you don't waste time with suppliers who can't meet your volume needs. One common mistake first-timers make is negotiating an MOQ verbally, then discovering the low number only applies to the formula production — not to custom packaging, inserts, or outer cartons, each of which may carry their own separate minimums. Always get a consolidated MOQ that covers all components in writing before signing a development agreement.

The fully-landed cost of a private label tranexamic acid and kojic acid eye serum varies widely based on four main cost drivers: the formula development fee, raw material cost of actives, packaging choice, and production volume. Formula development fees for a brightening eye serum typically range from $1,500 to $8,000 for a custom brief. If you use a manufacturer's stock base formula with minimal changes, some suppliers waive this fee entirely or fold it into the unit cost. Development fees are generally a one-time charge and are sometimes refundable against your first production order once you hit a certain volume. Raw material costs for the actives themselves — tranexamic acid and kojic acid — are not extreme, but they do affect unit economics. Tranexamic acid in cosmetic grade runs roughly $30–$80 per kilogram depending on source and purity specification. Kojic acid is similarly priced. At a 2–3% TXA and 1% kojic acid load in a 15 mL fill, the active cost per unit is a fraction of a dollar, but it adds up across thousands of units and affects pricing relative to a plain moisturizer base. Unit costs for the finished, filled, and labeled product break down approximately as follows for a 15–20 mL eye serum: $5–$10 per unit at 100–300 units from a stock formula, $7–$14 per unit at 300–1,000 units for semi-custom, and $10–$18 per unit for fully custom development at 500–2,000 units. These ranges assume basic airless pump or dropper packaging; upgrading to premium glass with a metal collar or custom-molded components can add $2–$6 per unit. Testing adds cost that first-timers often underestimate. Stability testing (accelerated 3-month minimum), challenge testing (preservative efficacy), and an HRIPT (human repeat insult patch test) together can run $3,000–$10,000 for a new formula. Some manufacturers bundle basic stability and challenge testing into their development fee; others charge separately. Domestic US manufacturing is more expensive on a per-unit basis — often 20–40% higher than South Korean or Chinese manufacturers — but eliminates import duties, reduces shipping lead time, and simplifies FDA compliance for US retail distribution. AJ Cosmo Labs makes cost comparison practical: post your brief in the iOS app and receive itemized quotes from multiple vetted manufacturers so you can benchmark development fees, unit costs, and testing inclusions side by side before committing.

The total timeline from initial brief to finished inventory for a private label tranexamic acid and kojic acid eye serum ranges from 4 weeks at the absolute minimum (stock base, existing packaging, rush production) to 24 weeks or more for a fully custom formula with bespoke packaging components. Here is how the timeline breaks down stage by stage. Brief and manufacturer selection typically takes 1–3 weeks if you are researching suppliers independently, or significantly less if you use a sourcing platform like AJ Cosmo Labs where vetted manufacturers can respond to your posted brief within days. Formula development and prototype production runs 2–8 weeks depending on complexity. For a stock base with minor modifications, a cosmetic chemist may turn around a prototype in 1–2 weeks. For a fully custom formula targeting a specific texture, pH, active profile, and sensory finish, expect 4–8 weeks of iterative lab work. Stability testing is the timeline anchor that most founders underestimate. Accelerated stability at 40°C/75% relative humidity runs a minimum of 4 weeks, with 8–12 weeks being the industry-recommended window before launch. Kojic acid is particularly vulnerable to oxidation and pH drift, so stability data is not optional — it protects your brand from discoloration complaints after products reach consumers. Real-time stability data (25°C/60% RH) should run concurrently to support a 12- or 24-month shelf life claim. Regulatory and label review adds 1–2 weeks if you have a qualified cosmetic regulatory consultant reviewing your INCI list, claims, and any market-specific requirements (EU CPNP, Prop 65). Packaging procurement is often the longest single variable if you are sourcing custom components. Stock packaging from a manufacturer's in-house inventory ships in days. Custom-molded or decorated packaging from an overseas supplier can add 8–14 weeks and its own MOQ. Production and filling for an order of 300–1,000 units typically takes 1–3 weeks once raw materials and packaging are confirmed on hand. Quality control, batch records, and certificate of analysis generation add a few business days. Shipping and customs clearance adds 3–5 business days for domestic freight and 3–6 weeks for ocean freight from Asia. Bottom line: plan for 12–16 weeks as a realistic launch timeline for a semi-custom formula with standard stock packaging, and 18–24 weeks if you are doing anything bespoke. Build 4 weeks of buffer into any retail launch commitment.

Tranexamic acid is most commonly used in cosmetic brightening formulas at concentrations between 2% and 5%. The majority of published cosmetic clinical studies on TXA for hyperpigmentation used concentrations in the 2–3% range applied twice daily, and this has become the benchmark that informed cosmetic chemists reference for a consumer-safe, efficacious formulation. Going above 5% does not necessarily improve efficacy and may increase sensitization risk in the thin periorbital skin; most experienced formulators keep eye-area TXA at 2–3%. Kojic acid is effective at lower concentrations. The industry standard is 0.5–2%, with 1% being the most commonly used concentration in brightening products. For eye-area use specifically, erring toward the lower end of that range — 0.5–1% — is prudent given the sensitivity of periorbital skin and the fact that kojic acid is a known sensitizer at higher concentrations. The EU has proposed restricting kojic acid to 1% in leave-on products, so formulating at or below 1% future-proofs your product for European market entry. The synergy between TXA and kojic acid is well-recognized among cosmetic chemists: they inhibit melanin synthesis through different mechanisms (TXA disrupts plasmin-mediated arachidonic acid release and UV-induced melanocyte activation; kojic acid chelates copper in tyrosinase and directly inhibits the enzyme), so their combined effect is additive and allows each to be used at a lower individual concentration than would be required if used alone. pH management is critical for kojic acid stability. Kojic acid is most stable below pH 5.5 and will oxidize and turn yellow-brown above that range, ruining the product aesthetically. A formula containing both TXA and kojic acid should be buffered to pH 4.5–5.5, which also happens to be favorable for skin barrier integrity in periorbital skin. When reviewing a manufacturer's stock brightening eye serum base, always request the pH specification and active concentration ranges in writing. If a manufacturer cannot provide a validated concentration for their actives or shows you a formula that runs at pH 6+, that is a red flag for kojic acid stability. Additional actives that pair well and that manufacturers commonly include in brightening eye serum bases include niacinamide (2–5%), alpha arbutin (1–2%), and peptides such as acetyl tetrapeptide-5. These can round out an efficacious, multi-pathway brightening formula without dramatically increasing cost. AJ Cosmo Labs connects you with cosmetic chemists and contract manufacturers who can walk you through active concentration decisions specific to your target market and claims strategy — download the iOS app to post your brief and specify your preferred active range upfront.

Selecting a cosmetic contract manufacturer for an eye serum with high-activity brightening ingredients requires more rigorous vetting than a simple moisturizer private label. Here are the certifications and qualifications that matter most. ISO 22716 (Good Manufacturing Practices for Cosmetics) is the baseline international standard. This certification means the facility has documented SOPs for raw material testing, production environment controls, batch traceability, and finished product quality release. For eye-area products with actives that are prone to degradation or sensitization, ISO 22716 compliance is non-negotiable — do not work with a manufacturer who cannot produce their certificate. FDA facility registration is important for US-market brands. While the FDA does not formally approve cosmetics before sale, the Modernization of Cosmetics Regulation Act of 2022 (MoCRA) now requires cosmetic manufacturers and facilities to register with the FDA and submit product listings. Working with an already-registered facility simplifies your compliance burden significantly. Dermatologist-tested and ophthalmologist-tested documentation is especially relevant for eye serums. These are not certifications in the regulatory sense but are clinical or panel-review validations that document the product was assessed on or near eye skin without adverse findings. Many retailers and wholesale buyers look for this language as a minimum before accepting an eye-area SKU. Preservative efficacy testing (PET / challenge test) per USP 51 or ISO 11930 is a must-have for any water-containing leave-on product near the eye. Request the actual test report, not just the manufacturer's assurance. Gluten-free, vegan, and cruelty-free certifications (Leaping Bunny, PETA, EWG Verified) are not regulatory requirements but are strong commercial differentiators in the brightening serum category and may be required by certain retailers or markets. For EU distribution, your manufacturer must be able to support your Cosmetic Product Notification Portal (CPNP) submission and provide the Product Information File (PIF) documentation including the cosmetic product safety report (CPSR) authored by a qualified safety assessor. Reach out to manufacturers through AJ Cosmo Labs — the platform's admin review process screens applicants, so you are starting from a qualified pool rather than cold-researching unknown suppliers. Download the iOS app from the App Store to browse manufacturer profiles that display their certifications upfront.

Yes, you can sell a private label tranexamic acid and kojic acid eye serum in the European Union, but there are specific regulatory requirements you must meet before placing the product on the EU market, and one active ingredient — kojic acid — carries a status you need to monitor closely. The EU Cosmetics Regulation (EC) No 1223/2009 governs all cosmetic products sold in the EU. Under this framework, you must appoint a Responsible Person (RP) established within the EU — this is the legal entity responsible for the product's regulatory compliance. The RP must maintain a Product Information File (PIF) including the formula, manufacturing details, safety assessment, and stability data. They are also responsible for submitting a CPNP (Cosmetic Products Notification Portal) notification before the product goes on sale in any EU member state. Transexamic acid is permitted as a cosmetic ingredient in the EU with no specific concentration restriction at this time, making it a straightforward active for EU market entry at the 2–3% range used in most formulas. Kojic acid is where EU compliance becomes more complex. As of the most recent SCCS (Scientific Committee on Consumer Safety) opinions, kojic acid has been assessed and found to be of concern at concentrations above 1% in leave-on products. The EU has been moving toward restricting kojic acid in leave-on products to 1% maximum. Always verify the current status with a qualified EU regulatory consultant at the time of your launch, as the regulatory landscape for this ingredient is actively evolving. Formulating at or below 1% kojic acid provides the most defensible compliance position for EU market entry. You will also need a Cosmetic Product Safety Report (CPSR) authored by a qualified safety assessor (typically a toxicologist) covering both the individual ingredient safety and the finished product safety. For a brightening eye serum with TXA and kojic acid, expect the safety assessor to scrutinize the kojic acid sensitization data specifically. Labeling in the EU requires ingredient listing in INCI nomenclature in descending order of concentration, a minimum 2-year shelf life or PAO (period after opening) symbol if shelf life exceeds 30 months, and all mandatory label fields (net content, RP name and address, country of origin, product function, precautions) in the language of the country of sale. For brands new to EU market entry, partnering with an experienced EU Responsible Person service and a cosmetic regulatory consultant before finalizing your formula is strongly recommended. AJ Cosmo Labs can connect you with formulators and regulatory partners familiar with EU brightening category requirements through the iOS app.

Finding a vetted private label manufacturer for a tranexamic acid and kojic acid eye serum specifically — rather than a generalist cosmetics co-packer — requires targeting suppliers with demonstrated experience in active-ingredient serums, periorbital formulation, and the stability management that brightening actives demand. The traditional approach is trade show sourcing (Cosmoprof, Making Cosmetics, PCHi) or cold outreach to manufacturers discovered through ingredient supplier referrals. This works but is slow: trade show attendance costs thousands of dollars, cold email response rates for small indie brands are low, and vetting each manufacturer's GMP status, MOQ, and experience individually can consume weeks. A faster and more targeted approach is to use AJ Cosmo Labs, a B2B marketplace and iOS app built specifically to connect cosmetic founders with vetted contract manufacturers, formulators, and packaging suppliers. You post a brief describing your project — actives (TXA at 2–3%, kojic acid at 0.5–1%), fill volume (15–20 mL), packaging preference, MOQ range, and timeline — and manufacturers who are a fit respond directly. The platform pre-screens suppliers through admin review so you are not starting from scratch on vetting. When evaluating any manufacturer for this specific formula, ask for the following before signing anything: (1) a sample or reference product with TXA and kojic acid in their existing portfolio, (2) stability data for their brightening serum base at 40°C/75% RH for at least 8 weeks, (3) their pH specification for the finished formula and how they control kojic acid oxidation, (4) their certificate of analysis format and what parameters are tested on each batch, (5) their packaging compatibility testing process, particularly for kojic acid in the presence of light and oxygen, and (6) a clear breakdown of their MOQ — separately for formula production and packaging components. Also verify that the manufacturer carries product liability insurance and is willing to sign an NDA before you share proprietary formula details. For US distribution, confirm they are registered with the FDA under MoCRA. Download AJ Cosmo Labs from the App Store, post your brightening eye serum brief, and let qualified manufacturers come to you — it is the most efficient first step for an indie founder sourcing a low-MOQ private label brightening eye serum.